Nova Nordisk Expects Victoza Sales To Grow In Japan
This article was originally published in PharmAsia News
Executive Summary
Amid several high profile diabetes drug launches in Japan, Nova Nordisk expects sales for its newly launched Victoza (liraglutide) to grow steadily